Clinical Trial Update: A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating oral upadacitinib versus placebo in adults with moderate to severe hidradenitis suppurativa has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Hidradenitis Suppurativa (HS) | Phase 2 | Status: COMPLETED | Results posted: 2023-02-06